Luxna Biotech Co., Ltd.
Licensing announcements since 2025
| Date | Counterparty | Asset / platform | Upfront | Near-term | Potential total | Stage at announcement |
|---|---|---|---|---|---|---|
| 2026-08-31 | Servier | XNAs antisense oligonucleotide technology; license option | Not disclosed | Not disclosed | Not disclosed | Not disclosed |